MRNA-2752 by Moderna for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval

MRNA-2752 is under clinical development by Moderna and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer).

Dec 22, 2023 - 18:00

MRNA-2752 is under clinical development by Moderna and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer).

Read the original article

Tags:

Previous Article

Imvotamab by IGM Biosciences for Rheumatoid Arthritis: Likelihood of Approval

Cadonilimab by Akeso for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood o...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Not-for-profit CommonSpirit Health paid its CEO $35 million in 2021

STAT+: Not-for-profit CommonSpirit Health paid its CEO ...

Aug 15, 2023

FDA issues complete response to Daiichi Sankyo-MSD’s BLA for NSCLC

FDA issues complete response to Daiichi Sankyo-MSD’s BL...

Jun 28, 2024

STAT+: Rune Labs, which makes an app to track Parkinson’s symptoms, raises $12 million

STAT+: Rune Labs, which makes an app to track Parkinson...

Jan 12, 2024